Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by BUZELLO, W
Right arrow Articles by SCHUCKEWEI, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BUZELLO, W
Right arrow Articles by SCHUCKEWEI, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1982, Vol. 54, No. 5 529-534
© 1982 The Board of Management and Trustees of the British Journal of Anaesthesia

research-article

HAZARDS OF NEOSTIGMINE IN PATIENTS WITH NEUROMUSCULAR DISORDERSReport of two cases

Reports of two cases

W BUZELLO, M.D, N. KRIEG, M.D and A. SCHUCKEWEI, M.D

Institut fur Anaesthesiologie der Universitäuklmiken Hugstet-ter Str. 55, D-7800 Freiburg, Federal Republic of Germany

In a 57-yr-old female with dystrophia myotonica, attempts to reverse residual non-depolanzmg block with neostigmine 1.0 mg were only partially effective and the administration of a further dose (0.5 mg) produced long-lasting muscle weakness. The train-of-four response of this patient resembled that of a depolarizing block and suggested an alteration in the electrical properties of the muscle membrane A 50-yr-old male with a 30-yr history of progressive muscle dystrophy, exhibited a tonic response to neosugmine in the evoked mechanomyograM.During recovery from partial neuromuscular block. It is concluded that the type of reaction to neostigmine in patients with neuromuscular disease is unpredictable.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
J. Parness, O. Bandschapp, and T. Girard
The Myotonias and Susceptibility to Malignant Hyperthermia
Anesth. Analg., October 1, 2009; 109(4): 1054 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. Bennun, B. Goldstein, Y. Finkelstein, and R. Jedeikin
Continuous propofol anaesthesia for patients with myotonic dystrophy
Br. J. Anaesth., September 1, 2000; 85(3): 407 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. A. Frankowski, J. O. Johnson, and J. D. Tobias
Rapacuronium Administration to Two Children with Duchenne's Muscular Dystrophy
Anesth. Analg., July 1, 2000; 91(1): 27 - 28.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
M.E. McLeod and R.E. Creighton
Review Article: Anesthesia for Pediatric Neurological and Neuromuscular Diseases
J Child Neurol, July 1, 1986; 1(3): 189 - 197.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.